It has been shown that in human lung inflammation, miR-223 can alleviate the inflammation caused by the release of inflammatory factors in the lung by directly targeting the 3′ UTR of RHOB, and low expression of RHOB has been closely associated with a lack of NF-κB signaling pathway activity [11]. This evidence concerns the gene NFKB1 and inflammation.